SCHEMBL27770207

SCHEMBL27770207

CN(C)N(C(N)=O)S(N)(=O)=O

nearest known ligand 0.33

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
F2 P00734 2/20 0.33
PRSS1 P07477 2/20 0.33
PRSS2 P07478 2/20 0.33
PRSS3 P35030 2/20 0.33
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6013582 0.72
SCHEMBL7581203 0.67 F2 (0.36) F2PRSS1PRSS2PRSS3
SCHEMBL28640678 0.63
SCHEMBL2053412 0.63
SCHEMBL23242 0.62
SCHEMBL21811 0.62
SCHEMBL75527 0.62
SCHEMBL27985624 0.62 ALDH1A1 (0.47) F2PRSS1PRSS2PRSS3
SCHEMBL24393027 0.62 CA1 (0.32) F2PRSS1PRSS2PRSS3CA1
SCHEMBL10351302 0.62 F2 (0.37) F2PRSS1PRSS2PRSS3CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101646674-B Indolobenzazepine derivatives for the treatment of hepatitis c BRISTOL MYERS SQUIBB CO 2013-05-29 CN disclosed
CN-101646674-A The indoles and the benzoazepine derivative that are used for the treatment of hepatitis C SQUIBB BRISTOL MYERS CO US 2010-02-10 CN disclosed